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Neonatal ureteral obstruction stimulates recruitment of renin-secreting
renal cortical cells. Unilateral ureteral obstruction (UUO) in the neonate
increases ipsilateral renal renin gene expression, an effect which is
mediated by renal nerves. To determine whether neonatal UUO alters
the number of renal cortical cells secreting renin and whether this
change is modulated by renal nerve activity, newborn Sprague-Dawley
rats were subjected to left UUO, right uninephrectomy, or sham
operation and studied four weeks thereafter. To evaluate the impor-
tance of renal nerves in this response, an additional group of animals
underwent chemical sympathectomy with guanethidine. Ureteral ob-
struction was associated with marked reduction in renal mass in the
obstructed kidney and contralateral compensatory hypertrophy,
changes which were not altered by sympathectomy. Renin messenger
RNA and renal renin content were elevated in the obstructed kidney.
The number of cells secreting renin, measured by the reverse hemolytic
plaque assay, was markedly increased in the obstructed kidney (45 18
plaques/slide vs. 11 1 plaques/slide in sham animals), but not in the
opposite kidney or following uninephrectomy. This effect was not
significantly altered by sympathectomy. There was no change in the
amount of renin secreted per cell or in the secretory response to Ca.
These results show that UUO results in recruitment of cells not
previously secreting renin by a mechanism independent of renal nerve
activity. This recruitment occurs without alteration of the quantity of
renin secreted per cell or in the normal regulatory effect of Ca on
renin secretion. An increase in the number of renin-secreting cells may
contribute to the activation of the renin-angiotensin system, and thus to
the vasoconstriction observed following ureteral obstruction.
Ureteral obstruction is characterized by alterations in renal
growth and hemodynamics which may ultimately lead to loss of
renal function. Acute ureteral clamping in isolated perfused dog
kidneys leads to increased renin secretion as measured by the
arteriovenous gradient in plasma renin activity [1, 2], but these
studies utilized the generation of angiotensin I as an indirect
measure of renin activity and do not distinguish between
angiotensin peptides produced by renin or other proteases such
as cathepsins or kallikrein [3—5]. The mechanism responsible
for the increase in renin secretion is unknown, and may be due
either to an increase in the number of cells secreting renin or an
increase in the amount of renin secreted per cell. Other studies
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have documented ipsilateral increases in angiotensin II gener-
ation following acute UUO, further suggesting that changes in
renin secretion may be responsible for alterations in renal
hemodynamics [61.
In developing animals, the highly activated state of the
renin-angiotensin system plays a central role in the production
and maintenance of renal vasoconstriction following chronic
unilateral ureteral obstruction (UUO) [7—11]. Developing kid-
neys demonstrate an increased abundance and distribution of
renin mRNA and renin protein throughout the renal microvas-
culature as compared to mature animals [12—17]. Kidneys
subjected to chronic ipsilateral UUO during early postnatal
development express elevated renin mRNA levels in the juxta-
glomerular apparatuses (JGAs), increased numbers of JGAs
which contain immunoreactive renin, and an expanded distri-
bution pattern of renin within the renal vasculature [18]. In
contrast, mature rats and mice subjected to UUO develop an
ipsilateral increase in the percentage of JGAs containing renin
but no change in the upstream distribution of renin or its mRNA
[11, 19]. Neonatal animals subjected to UUO also develop
arrested growth of the obstructed kidney and compensatory
hypertrophy of the intact opposite kidney which is proportion-
ately greater than that seen in adult animals with chronic UUO
[11, 20—23]. We have shown that alterations in renin gene
expression and renin protein distribution following UUO are
modulated by renal nerves [24].
The aforementioned experiments suggest that increased renin
secretion in the setting of UUO may be mediated by an
increased number of cells secreting renin, in the amount of
renin secreted per cell, or both. Experiments were therefore
designed to test the hypothesis that increased renin gene
expression and enhanced renin protein distribution in kidneys
ipsilateral to UUO are associated with secretion of renin by an
increased number of renal cortical cells. These studies included
evaluation of the amount of renin secreted per cell, regulation of
secretion by ambient calcium concentration and modulation of
these effects by the renal sympathetic nervous system.
The reverse hemolytic plaque assay was chosen as a method
of identification and quantitation of isolated cells secreting
renin. This assay has been successfully utilized to identify
hormone secretion by individual cells within heterogeneous cell
populations [25—27] and obviates the requirement for a prepa-
ration of pure juxtaglomerular cells. This method specifically
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detects cells which secrete renin and/or prorenin without cross
reactivity with closely related proteases [28], and permits
quantitation of hormone secretion [29].
Methods
Animal preparation
Newborn Sprague-Dawley rats less than 48 hours of age were
subjected to complete left ureteral obstruction (UUO, N = 31),
right uninephrectomy (UniNX, N = 7), or sham operation
(Sham, N = 20) under general anesthesia with halothane and
oxygen. Following a small incision in the abdomen, the left
ureter was ligated (UUO) or identified and left undisturbed
(Sham). For uninephrectomy, an incision was made in the right
flank, the right renal pedicle was ligated, and the kidney was
excised. All incisions were closed in one layer and the animals
were allowed to recover from anesthesia prior to returning them
to their mothers. All pups were nursed by their mothers until 21
days of age at which time they were maintained on regular rat
chow (Purina 5012, Ralston-Purina, St. Louis, Missouri, USA)
and ad libitum tap water.
Sympathectomy protocol. Renal denervation can be effected
by administration of guanethidine in early postnatal life [30]. A
group of animals with UUO was subdivided into two groups:
chemical sympathectomy with guanethidine (UUO + G, N =
11) and sham sympathectomy with vehicle alone (UUO + NS,
N = 10). A group of sham-operated animals also received
guanethidine (Sham + G, N = 5) or saline vehicle (Sham + NS,
N 5). Injections were begun with guanethidine or saline five
days following surgery. Guanethidine monosulfate (CIBA-
Geigy Pharmaceuticals, Summit, New Jersey, USA) was given
as a daily subcutaneous dose of 50 mg/kg diluted in 0.9% saline
to yield a final volume of 5 pJ/g body weight. Equal volumes of
saline were administered to animals treated with vehicle. All
animals received injections six days per week for a total of 15
injections following a minor modification of the protocol of
Johnson, O'Brian and Werbitt [30].
Five animals in each group were utilized for determination of
renal renin content, renal renin mRNA, and renal norepineph-
rime levels.
At 28 to 31 days of age, following overnight fast with free
access to water, the animals were killed by decapitation and
kidneys processed for study as described below.
Reverse hemolytic plaque assay
Following the methods of Carey et al [28], the abdominal
aorta was catheterized and the kidneys perfused with RPMI
1640 media containing 0.1% collagenase A (Boehringer Mann-
heim, Indianapolis, Indiana, USA), 0.12 mg/mI type III elas-
tase, 0.25 mg/mI soybean trypsin inhibitor, 0.16 mg/mi deoxyri-
bonuclease I (DNase), 0.3% bovine serum albumin, 100 U/mI
penicillin, and 100 pg/mI streptomycin (Penicillin/streptomycin
= P/S) (all from Sigma Chemical, St. Louis, Missouri, USA).
The kidneys were excised, weighed, decapsulated, hemisected,
demedullated and the cortices were minced. The minced tissue
from each kidney was diluted to 25 ml with the enzyme solution
described above and incubated with gentle stirring at 37°C.
Following 30 minutes of incubation, the cell suspension was
gently homogenized by repeated glass pipette action, gassed for
one minute with 95% air-5% C02, and returned to the bath for
15 minutes. The suspension was allowed to settle for three
minutes, and the supernatant was aspirated and saved. Fresh
enzyme solution (to 25 ml) was added to the remaining tissue,
and the solution was returned to the water bath for two
additional dispersion cycles. The enzyme solution containing
the isolated cells was immediately inhibited by the addition of
20% (vollvol) fetal bovine serum followed by dilution with
ice-cold RPM! 1640 containing 0.1% BSA and penicillin/strep-
tomycin (RPMI-BSA-P/S). The cells were recovered by centrif-
ugation, resuspended in RPMI-BSA-PIS containing 0.016 mg/mI
DNase, and maintained with gentle stirring at 30°C. The super-
natants from the remaining enzyme incubations were treated
identically and added to the cells in the 30°C bath. Following
two washes with RPMI-BSA-P/S and recovery by centrifuga-
tion, the isolated cells were subjected to density-gradient cen-
trifugation through 40% isosmotic Percoll (Sigma). The layer of
cells corresponding to a density of 1.06 g/mi (designated 40-2
layer) was carefully aspirated, washed free of Percoll, and
resuspended in RPMI-BSA-P/S to a final volume of 1.0 x iO
cells per ml. The cells layering to a density of 1.03 g/ml (40-1
layer) were similarly recovered and stored for determination of
renin content as described below. Cell viability was determined
by Trypan blue exclusion, and only preparations containing
>90% viable single cells were utilized for the remainder of the
assay.
Protein A-conjugated ovine erythrocytes were prepared as
described by Carey et al [28] and mixed with an equal volume of
the 40-2 kidney cell suspension. Thirty microliters of the cell
mixture were plated onto poly-L-lysine coated Cunningham
chambers and allowed to adhere. The chambers were filled with
75 jsl of a 1:60 dilution of lyophilized rabbit polyclonal antibody
to rat renin (gift of Dr. T. Inagami) in RPMI-BSA-P/S contain-
ing CaCI2 at a final concentration of calcium of 0.4 m or 2.5
mM.
Guinea pig complement was then added to each chamber
followed by incubation for an additional 30 minutes. Following
the development of hemolytic plaques, the slides were fixed,
stained, and covered with coverslips. Plaque numbers were
counted by direct microscopic visualization (lOx magnifica-
tion). To estimate the amount of renin secreted per cell, the
areas of all plaques were measured using an Orthoplan micro-
scope (Zeiss) and a Videoplan computer.
Renal renin content and renin content of 40-1 and 40-2 layers
Renin contents of intact kidney and of the isolated 40-1 and
40-2 layers were ascertained by angiotensin I (Ang I) generation
and radioimmunoassay as described by Sealy and Laragh [31]
using an excess of rat angiotensinogen. Concentrations were
expressed as nanograms of angiotensin I/hr/mg protein. Protein
content of the samples was measured by the method of Brad-
ford [32].
Renin mRNA analysis
Tissue was pooled from the left or right kidneys from five
animals which had undergone UUO or sham operation with
guanethidine or saline vehicle as described above. Total kidney
RNA was extracted using the method of Chirgwin et al [33]. Ten
to 15 pg samples were separated by 1.2% agarose-formaldehyde
gel electrophoresis and transferred to a nylon membrane by
capillary action (Northern blot) as previously described [34].
a
 a
 
$ 
a
 a
 
•
 
I 
a
. 
Norwood et al: Renin secretion post-obstruction 1335
Body wt
g
Left
kidney wt
Right
kidney wt
Left
ureteral
diameter
mmgIIOO g body wt
Sham 92.3 5.4 0.56 0.03 0.60 0.04 0.9 0.03
N = 10
Sham + NS 90.7 4.9 0.48 o.ola 0.48 o.Ola 0.8 0.04
N = 5
Sham + G 70.9 3.l° 0.49 0.02° 0.50 0.01° 0.8 0.1
N= 5
Right 73,0 4.80 1.07 0.05° NA 0.9 0.05
nephrectomyN= 7
UUO 84.5 5.3 0.29 0.04° 0.86 007a.b 2.7 0.4k'
N = 10
UUO + NS 77.2 5.8 0.32 0.03° 0.86 004a,b 3,3 4a
N = 10
IJUO + G 70.5 5.0° 0.26 0.03° 0.88 0.05' 3.0 Ø3
N= 11
Values are expressed as mean SEM. Abbreviations are: NS, normal
saline; G, guanethidine.
a < 0.05 vs. shamb P < 0.05 vs. left kidney
' P < 0.05 vs. corresponding saline control
Using the methods of Church and Gilbert [35], the RNA
samples were hybridized to a full-length rat renin cDNA (gift of
Dr. K. Lynch, University of Virginia, Charlottesville, Virginia)
labeled with 32P by the random priming method [36]. Renin
mRNA was detected by autoradiography and quantitated by
densitometric analysis using an Ultrascan XL laser densitome-
ter (LKB Instruments, Inc., Bromma, Sweden). As the control
for RNA loading and specificity of changes, the Northern blot
was also hybridized to a 32P-labeled 780 bp cDNA fragment of
human glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(American Type Culture Collection, Rockville, Maryland,
USA). Four Northern blots were analyzed for reproducibility.
Renal norepinephrine content
Norepinephrine content of kidney tissue was determined by
HPLC with electrochemical detection, performed in the labo-
ratory of Dr. Pedro Jose, Georgetown University.
Statistical analysis
Left and right kidneys were compared by Student's t-test for
paired data. Comparisons between treatment groups were per-
formed by one way analysis of variance. Plaque numbers were
expressed as mean per slide SEM and comparisons between
groups were analyzed by Kruskal-Wallis one way analysis of
variance for non-parametric data. For results of plaque area
data, frequency distribution curves were constructed and com-
pared using chi-square analysis. Statistical significance was
defined as P < 0.05.
Results
Effect of surgical procedure and guanethidine on somatic and
kidney growth
As shown in Table 1, chronic left UUO was associated with
significant ureteral dilatation ipsilateral to the ligation. When
B
( 2.4 kb
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Fig. 1. Renin mRNA. A. Northern blot of pooled total RNA (15 tg)
from left (LK) and right (RK) kidneys from obstructed animals which
received saline (UUO), sham animals receiving saline (Sham), sham
plus guanethidine (Sham + G), and obstructed animals plus guanethi-
dine (UUO + G) hybridized to a 32P-labeled cDNA to rat renin. B. Same
Northern blot from Figure 1A hybridized to GAPDH cDNA.
compared to sham-operated animals, UUO also resulted in
reduced renal mass in the obstructed kidney and contralateral
compensatory hypertrophy without alteration in somatic
growth. Animals receiving guanethidine exhibited decreased
weight gain when compared to saline-treated or non-treated
controls. The side effects of chronic administration of guaneth-
idine include jitteriness and mild diarrhea which may affect
nutritional balance during both the pre- and post-weaning
periods and thus account for reduced somatic growth. Impor-
tantly, however, there was no effect of guanethidine on ureteral
dilation or renal growth when corrected for body weight. Right
uninephrectomy was studied as an alternate stimulus for com-
pensatory hypertrophy independent of ureteral obstruction;
compensatory renal growth of the remaining kidney was similar
to that of the intact kidney contralateral to UUO.
Renin mRNA analysis
Shown in Figure 1A is a representative Northern blot probed
for renin mRNA from animals subjected to UUO or sham
operation with and without chemical sympathectomy with
guanethidine. Figure lB shows the same Northern blot hybrid-
ized to GAPDH as control for RNA loading and specificity of
changes. Following correction for GAPDH signal and compar-
ison to sham animals, renal renin mRNA was increased approx-
imately twofold in obstructed kidneys (2.1 0.2 optical density
units, P < 0.002) and suppressed by approximately 50% in
kidneys contralateral to UUO (0.5 0.01 optical density units,
P < 0.001). Sympathectomy did not alter the increase in renin
gene expression induced by UUO or alter the suppression of
renin gene expression in the kidney contralateral to UUO.
Guanethidine therapy did not significantly alter renin gene
expression in sham-operated animals.
Table 1. Effects of obstruction and guanethidine on kidney growth
and body weight
A
a: -J
o 0 oo
.z .
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Left kidney Right kidney
renin content renin content
ng Ang I/hr/mg protein
Sham 35.9 (27.7—41,8) ND
(N =3)
UUO 183.9 (70.0—287.6) 14.5 (5.7—23.0)(N = 3)
Right nephrectomy 66.4 (42.7—91.2) NA
(N =3)
UUO + G 111.8 (70.0—158.3) 22.4 (14.1—34.3)(N = 3)
Sham + G 38.9 (31.5—44.6) ND(N=3)
Layer
Sham(N = 5)
UUo
Left
kidney(N = 6)
Right
kidney(N = 6)
40-1 15.7 6.0 56.6 16.3 15.0 0.5
40-2 114.9 19.1 306.2 78.Oa 333 7.oa
a < 0.05 vs. 40-1
Renal renin content and cell fraction renin content
Renal renin content was analyzed as a measurement of total
renin protein stores. As shown in Table 2, UUO resulted in an
increase in renal renin content in the ipsilateral kidney as
compared to control kidneys. Renal renin content was sup-
pressed in the intact contralateral kidney. Guanethidine treat-
ment did not significantly affect renal renin content in sham or
obstructed animals.
Renin content of the two primary fractions of cells isolated
from Percoll centrifugation (40-1 and 40-2) was analyzed in
order to determine if UUO altered the density-gradient distri-
bution of the cells. Table 3 shows that the 40-2 layer was
consistently enriched in renin-secreting cells as compared to the
40-1 fraction. When expressed as the ratio of renin activity in
the 40-2 layer to the 40-1 layer, there was no influence of
ipsilateral obstruction on the enrichment process (P = 0.32).
Renal norepinephrine content
Renal norepinephrine levels were determined to evaluate the
efficacy of chemical sympathectomy with guanethidine. Table 4
shows the renal norepinephrine levels in sham-operated and
obstructed animals following sympathectomy with guanethidine
or sham sympathectomy with saline vehicle. All kidneys from
guanethidine-treated animals showed significant suppression of
renal norepinephrine levels to approximately 20 to 25% of
control values (P <0.05).
Renin secretion
Compared to sham-operated controls, the number of cells
actively secreting renin was markedly increased in the kidney
with ipsilateral UUO (Fig. 2). There was, however, no change
Renal norepinephrine content
ng/g kidney weight
Saline Guanethidine
Sham — LK 83.1 8.0 18.7 2.5a
UUO — LK 139.5 38.5 28.6 8.7a
UUO — RK 79.2 13.0 19.0 5.6
Values are expressed as mean SEM. Abbreviations are: LK, left
kidney; RK, right kidney.a P < 0.05 vs. saline
in the number of renin-secreting cells in the intact opposite
kidney. The kidney remaining following uninephrectomy also
exhibited a proportion of renin-secreting cells similar to the
sham group. Chemical sympathectomy with guanethidine in-
creased the number of renin-secreting cells in the obstructed
kidney when compared to kidneys from non-treated or saline-
treated animals with UUO, but this change was not statistically
significant (P = 0.10). As tubular atrophy accounts for a
significant portion of the loss of renal mass following UUO [221,
it is possible that selective preservation of renin-secreting cells
with loss of other cell types exaggerated the apparent increase
in the number of cells secreting the enzyme. However, review
of the data in Table 1 and Figure 2 showed that obstructed
kidneys lost only approximately half of the renal mass of sham
kidneys and demonstrated a fourfold increase in the number of
renin-secreting cells. This increase was approximately twice
that which could be accounted for by dilution factors alone. The
lack of a decrease in the plaque numbers obtained from the
markedly hypertrophic kidneys remaining following uninephrec-
tomy also supported the conclusion that the results were not
affected by dilution of renin-secreting cells by other cell types.
As shown in Figure 3, renal cortical cells from all groups
responded to increased ambient calcium concentration (2.5 mM)
by suppression of the number of cells secreting renin. When
expressed as a ratio of plaques formed in 0.4 mr.i Ca to those
formed in 2.5 mrvi Ca , the degree of suppression of plaque
formation by high Ca was similar in all groups with the
exception of uninephrectomized animals in which the suppres-
sion of plaque formation was less than that in sham animals.
To examine potential changes in the amount of renin secreted
per cell, the distribution of renin-secreting cells was analyzed
according to plaque area. As shown in Figure 4, the population
of renin-secreting cells is not normally distributed with respect
to plaque area. Although the number of cells secreting renin is
markedly increased by UUO, there is no shift in the distribution
of plaque area in response to UUO or sympathectomy. Figure
5 illustrates the distribution of plaque area as a percent of the
total number of plaques and reveals that the proportion of the
cell population secreting a given amount of renin does not
change following UUO or sympathectomy. These results indi-
cate that the amount of renin secreted per cell is not altered by
UUO or renal nerve activity. Moreover, the recruited cell
population secretes renin in quantities not different from cells
which secrete renin in unstimulated conditions.
Discussion
The results of the present study indicate that chronic unilat-
eral ureteral obstruction in developing rats results in an in-
creased proportion of renal cortical cells which secrete renin.
Table 2. Renin analysis Table 4.
Values are expressed as mean (range). Abbreviations are: ND, not
done; NA, not applicable.
Table 3. Renin activity (ng Ang I/hr/mg protein)
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Increased renin gene expression and renal renin content also
result from ipsilateral UUO, a finding which corroborates
earlier studies from our laboratory [181. Furthermore, these
studies demonstrate that increased renin release in the setting of
UUO is due to a resourceful mechanism—the recruitment of
cells not previously secreting renin.
The pattern of renin secretion as described by the heteroge-
neous population distribution of plaque areas reveals a unimo-
dal curve which is not normally distributed. This pattern is
unaffected by UUO suggesting that the recruitment of cells to
secrete the protein occurs in a pattern similar to that which
exists in unstimulated animals. Therefore, UUO results in an
overall increase in the number of cells secreting renin without
affecting the quantity of renin secreted per cell. These results
a)
E
a)
c,.
a)
a-
Area, pm2x 1000
Fig. 5. Percent distribution of plaque areas with ureteral obstruction
and guanethidine therapy. Values are expressed as percent of total
plaques at each size. Abbreviations are: UniNx, right nephrectomy; 0,
guanethidine; NS, normal saline. Symbols are: (0) UUO + G; ()
UUO + NS; () UUO; (0) UniNx; (*) Sham.
are consistent with studies of newborn renal microvessels by
Everett et al [37] in which the number of cells secreting renin
increased following adenylyl cyclase stimulation by forskolin
without change in the amount of renin secreted per cell. Other
studies have demonstrated similar increases in the number of
renin-secreting cells following angiotensin converting enzyme
inhibition [38] and salt-depletion [39]. These studies demon-
strated that the recruited cells appear to be juxtaglomerular
cells and/or vascular smooth muscle cells of the afferent arte-
riole. Presumably these cells are induced to transcribe and
translate the renin gene and appropriately process and secrete
the protein. The common final pathway leading to initiation of
renin gene expression is as yet unknown, but the recruitment of
cells which do not secrete renin in the basal state may represent
a)
E
C.)
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a)0
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Fig. 4. Frequency distribution of plaque areas with ureteral obstruc-(ion and guanethidine therapy. Values are expressed as total plaques of
each size. Abbreviations are: UniNx, right nephrectomy; G, guanethi-
dine; NS, normal saline. Symbols are: (0) UUO + G; (A) UUO + NS;
() UUO; (0) UniNx; (*) Sham.
30
25
C0
15
10
5
0
Sham UUO UniNx UUO+G UUO+NS
Operative group
Fig. 2. Effects of ureteral obstruction, unilateral nephrectomy, and
guanethidine therapy on plaque numbers. Symbols are: (0) left kidney;
(U) right kidney. Values are expressed as mean SEM. Abbreviations
are: UniNx, right nephrectomy; 0, guanethidine; NS, normal saline.
*p < 0.05 vs. sham. #P < 0.05 vs. right kidney.
100
a)
.C )
(a.
50C- —
a)
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0
Fig. 3. Effects of calcium concentration on plaque numbers. Symbols
are: (0)0.4mM Ca; (U)2.5mt Ca. Values are expressed as mean
SEM. Abbreviations are: UniNx, right nephrectomy; G, guanethidine;
NS, normal saline. P < 0.05 vs. 0.4 ms Ca.
Sham UUO UniNx UUO+G UUO+NS
Operative group
0 50 100 150 200 250
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a basic mechanism for enhancement of hormone secretion in
the kidney.
One explanation for the recruitment of renal cortical cells
secreting renin following UUO is a reduced sensitivity to
inhibitory stimuli controlling secretion. Under normal condi-
tions renin secretion can be inhibited by a number of factors
which include increased extracellular calcium concentration
[40], angiotensin II [41], renal denervation [42], and tubuloglo-
merular feedback [42]. The present study demonstrates that the
cells which secrete renin following UUO are suppressed by
increased extracellular calcium in the same fashion as control
cells indicating that the mechanism responsible for the inhibi-
tion of renin secretion by calcium is intact following UUO. In
contrast, cells recruited in the presence of enalapril do not
respond normally to changes in ambient calcium concentration
suggesting that separate regulatory mechanisms may be in-
volved in the two models [38]. Chemical sympathectomy with
guanethidine did not alter renin secretion following UUO.
These data suggest that the inhibitory effect of renal denerva-
tion is suppressed in this model. Chemical sympathectomy with
guanethidine had no effect on the suppression of renin secretion
by increased ambient calcium suggesting that the suppression of
renin secretion by calcium is independent of sympathetic con-
trol.
Previous studies from this laboratory revealed that renal
denervation attenuates the increase in renin gene expression
resulting from UUO [24]. Others have shown that renal dener-
vation in fetal sheep suppresses both renin gene expression and
plasma renin activity during the perinatal period [40]. In con-
trast, the present experiments do not show that denervation
significantly alters renin secretion by individual renal cortical
cells following UUO nor does renin gene expression appear to
be modulated by renal nerves. These differences may be
explained by the presence of a more severe obstruction in the
present study as suggested by ureteral diameter and kidney
weights. Although renin mRNA content and protein secretion
are both increased following UUO, these studies do not address
the possibilities of increased stability of renin mRNA, enhanced
translation of renin message, or alterations in the secretory
process which may result from UUO. Alternatively, UUO or
side effects of guanethidine may change renal hemodynamics
and/or tubular function such that baroreceptor or tubuloglomer-
ular feedback mechanisms which stimulate renin secretion
override the effects of sympathectomy to suppress renin secre-
tion. Vasoactive agents such as angiotensin II, prostaglandins,
dopamine, atrial natriuretic peptide, vasopressin, kinins, endo-
thelin, and nitric oxide may also directly or indirectly interact
with renal nerves to modulate renin secretion in this model.
Kidneys contralateral to UUO demonstrate compensatory
hypertrophy, but do not show a change in the proportion of
cells secreting renin even though renin gene expression and
renal renin content are suppressed. However, the total number
of cells secreting renin in these kidneys is small and may
preclude findings of statistical significance. Previous studies of
the kidney contralateral to UUO have demonstrated an increase
in immunoreactjve renin in the renal microvasculature without
an increase in renin mRNA in the juxtaglomerular apparatuses
[18]. This increase in renin immunostaining may result from
enhanced renin gene expression at an earlier timepoint follow-
ing ureteral obstruction and may represent renin stores which
are not secreted. In the current study, unilateral nephrectomy
was utilized as an alternate stimulus for compensatory renal
growth unrelated to ureteral obstruction. There were no differ-
ences in the degree of hypertrophy, the proportion of cells
secreting renin, or the inhibitory response to increased ambient
calcium concentrations between kidneys remaining after unine-
phrectomy or intact kidneys contralateral to UUO. These
findings correlate well with the studies of Pupilli et al in which
renin gene expression and protein distribution were not altered
by uninephrectomy [43].
In summary, these studies show that renin secretion is
enhanced following ipsilateral ureteral obstruction by a mech-
anism involving the recruitment of cells previously not secret-
ing renin. This increase in renin secretion may contribute to the
increased renal vascular resistance and decreased glomerular
filtration rate resulting from ipsilateral UUO. These findings
support the growing body of evidence that activation of the
intrarenal renin-angiotensin system is a key event in the patho-
physiology of obstructive uropathy during development.
Acknowledgments
Guanethidine monosulfate (Ismelin) was provided by CIBA-GEIGY
Pharmaceuticals, Summit, NJ. This work was supported by National
Institutes of Health Multidisciplinary Training Program in Urologic
Research T32DK07642 (Dr. Norwood), the Center of Excellence in
Pediatric Nephrology and Urology Grant DK-44756, the Child Health
Research Center HD28810, and the University of Virginia Vascular
Smooth Muscle Program Project Grant POl-4HL-19242 (Dr. Carey).
Dr. Chevalier is supported by NIH grants DK-40558 and HL-40209. Dr.
Gomez is supported by NIH grants HL-41899 and HL-02307.
Reprint requests to Victoria F. Norwood, M.D., Department of
Pediatrics, Division of Pediatric Nephrology, University of Virginia
Health Sciences Center, Box 386, Charlottesville, Virginia 22908, USA.
References
1. KALOYANIDES GJ, BASTRON RD, DIBONA OF: Effect of ureteral
clamping and increased renal arterial pressure on renin release. Am
J Physiol 225:95—99, 1973
2. EIDE I, LOYNING E, LANGARD 0, Kin. F: Mechanism of renin
release during acute ureteral constriction in dogs. Circ Res 40:293—
299, 1977
3, DORER FE, LENTz KE, KAHN JR. LEvINE M, SKEGOS LT: A
comparison of the substrate specificities of cathepsin D and pseu-
dorenin. JBiol Chem 253:3140—3142, 1978
4. MARUTA H, ARAKAWA K: Confirmation of direct angiotensin
formation by kallekrein. Biochem J 213:193—200, 1983
5. TONNESEN MG, KLEMPNER MS, AUSTEN F, WINTROUB BU:
Identification of a human neutrophil angiotensin IL-generating pro-
tease as cathepsin 0. J Clin Invest 69:25—30, 1982
6. FROKLAERJ, KNUDSEN L, NIELSEN AS, PEDERSEN EB, DJURHUUS
JC: Enhanced intrarenal angiotensin II generation in response to
obstruction of the pig ureter. Am J Physiol (Renal, Fluid Electrol
Physiol) 263:F527—F533, 1992
7. CHEVALIER RL, JONES CE: Contribution of endogenous vasoactive
compounds to renal vascular resistance in neonatal chronic partial
ureteral obstruction. J Urol 136:532—535, 1986
8. CHEVALIER RL, PEACH MJ: Hemodynamic effects of enalapril on
neonatal chronic partial ureteral obstruction. Kidney mt 28:891—
898, 1985
9. MCDOUGAL WS: Pharmacologic preservation of renal mass and
function in obstructive uropathy. J Urol 128:418—421, 1982
10. YARGER WE, SCHOCKEN DD, HARRIS RH: Obstructive nephropa-
thy in the rat: Possible roles for the renin-angiotensin system,
prostaglandins, and thromboxanes in postobstructive renal func-
tion. J Clin Invest 65:400—412, 1980
11. EL-DAHR SS, GOMEZ RA, KHARE 0, PEACH MJ, CAREY RM,
Norwood et a!: Renin secretion post-obstruction 1339
CHEVALIER RL: Expression of renin and its mRNA in the adult rat
with chronic ureteral obstruction. Am J Kidney Dis 15:575—582,
1990
12. GOMEZ RA, CHEVALIER RL, STURGILL BC, JOHNS DW, PEACH
MJ, CAREY RM: Maturation of the intrarenal renin distribution in
Wistar-Kyoto rats. J Hypertens 4 (Suppl 5):S31—S33, 1986
13. GOMEZ RA, LYNCH KR, STURGILL BC, ELWOOD JP, CHEVALIER
RL, CAREY RM, PEACH MJ: Distribution of renin mRNA and its
protein in the developing kidney. Am J Physiol 257:F850—F858,
1989
14. GOMEZ RA, LYNCH KR, CHEVALIER RL, EVERETT AD, JOHNS
DW, WILFONG N, PEACH MJ, CAREY RM: Renin and angiotensino-
gen gene expression and intrarenal renin distribution during ACE
inhibition. Am J Physiol 254:F900—F906, 1988
15. CELlO M, GROSCURTH P, INAGAMI T: Ontogeny of renin immuno-
reactive cells in the human kidney. Anat Embryo! 173:149—155,
1985
16. EGERER G, TAUGNER R, TIEDMANN K: Renin immunohistochem-
istry in the mesonephros and metanephros of the pig embryo.
Histochemistry 81:385—390, 1984
17. MINUTH M, HACKENTHAL E, POULSEN K, Rix E, TAUGNER R:
Renin immunocytochemistry of the differentiating juxtaglomerular
apparatus. Anal Embryo! 162:173—181, 1981
18. EL-DAHR SS, GOMEZ RA, GRAY MS, PEACH MJ, CAREY RM,
CHEVALIER RL: In situ localization of renin and its mRNA in
neonatal ureteral obstruction. Am J Physiol 258:F854—F862, 1990
19. KON Y, TAKAHASHI S. FUKAMIZU A, MURAKAMI K, HASHIMOTO
Y, SuGIMuRA M: Morphological and northern blot analysis of
juxtaglomerular cells in experimental hydronephrotic mice. Anal
Rec 232:393-400, 1992
20. CHEVALIER RL, KAISER DL: Chronic partial ureteral obstruction in
the neonatal guinea pig. I. Influence of uninephrectomy on growth
and hemodynamics. Pediatr Res 18:1266—1271, 1984
21. ZELMAN SJ, ZENSER TV, DAVIS BB: Renal growth in response to
unilateral ureteral obstruction. Kidney mt 23:594—598, 1983
22. CHEVALIER RL, STURGILL BC, JONES CE, KAISER DL: Morpho-
logic correlates of renal growth arrest in neonatal partial ureteral
obstruction. Pediatr Res 21:338—346, 1987
23. CHEVALIER RL: Chronic partial ureteral obstruction in the neonatal
guinea pig. II. Pressure gradients affecting glomerular filtration
rate. PediatrRes 18:1271—1277, 1984
24. EL-DAHR SS, GOMEZ RA, GRAY MS, PEACH MJ, CAREY RM,
CHEVALIER RL: Renal nerves modulate renin gene expression in
the developing rat kidney with ureteral obstruction. J Gun Invest
87:800—810, 1991
25. CHILDS GV, BURKE JA: Use of the reverse hemolytic plaque assay
to study the regulation of anterior lobe adrenocorticotropin
(ACTH) secretion by ACTH-releasing factor, arginine vasopressin,
angiotensin II and glucocorticoids. Endocrinology 120:439—444,
1987
26. DEFTOS U: Pituitary cells secrete calcitonin in the reverse hemo-
lytic plaque assay. Biochem Biophys Res Commun 1460:1350—1356,
1987
27. Ho KY, LEONG DA, SINTA YN, JOHNSON ML, EVANS WS,
THORNER MO: Sex related differences in OH secretion in rats using
reverse hemolytic plaque assay. Am JPhysiol 250:E650—E654, 1986
28. CAREY RM, GEARY KM, HUNT MK, RAMOS SP, F0REE5 MS,
INAGAMI T, PEACH Mi, LEONG DA: Identification of individual
renocortical cells that secrete renin. Am J Physiol 258:F649—F659,
1990
29. SMITH PF, LUQUE EH, NEILL JD: Detection and measurement of
secretion from individual neuroendocrine cells using a reverse
hemolytic plaque assay. Meth Enzymo! 124:443—446, 1986
30. JOHNSON EM JR, O'BRIEN F, WERBITr R: Modification and
characterization of the permanent sympathectomy produced by the
administration of guanethidine to newborn rats. Eur J Pharmacol
37:45—54, 1976
31. SEALEY JE, LARAGH JH: How to do a plasma renin assay.
Cardiovasc Med 2:1079—1092, 1977
32. BRADFORD MM: A rapid and sensitive method for the quantitation
of microgram quantities of protein utilizing the principles of pro-
tein-dye binding. Anal Biochem 72:248—254, 1976
33. CHIRGWIN JM, PRZYBYLA AE, MACDONALD RJ, RUITER WF:
Isolation of biologically active ribonucleic acid from sources en-
riched in ribonuclease. Biochemistry 18:5294—5299, 1979
34. THOMAS PS: Hybridization of denatured ribonucleic acid trans-
ferred or dotted onto nitrocellulose paper. Meth Enzymol 100:255—
266, 1983
35. CHURCH GM, GILBERT W: Genomic sequencing. Proc Nail Acad
Sci USA 81:1991—1995, 1984
36. FEINBERG AP, VOGELSTEIN B: A technique for radiolabelling DNA
restriction endonuclease fragments to high specific activity. Anal
Biochem 132:6—13, 1983
37. EVERETT AD, CAREY RM, CHEVALIER RL, PEACH MJ, GOMEZ
RA: Renin release and gene expression in intact rat kidney mi-
crovessels and single cells. J C!in Invest 86:169—175, 1990
38. GEARY KM, HUNT MK, PEACH MJ, GOMEZ RA, CAREY RM:
Effects of angiotensin converting enzyme inhibition, sodium deple-
tion, calcium, isoproterenol, and angiotensin II on renin secretion
by individual renocortical cells. Endocrinology 131:1588—1594, 1992
39. GOMEZ RA, CHEVALIER RL, EVERETT AD, PEACH MJ, CAREY
RM: Renin gene expression during salt depletion. (abstract) Kidney
Int 35:300, 1989
40. KEETON TK, CAMPBELL WB: The pharmacologic alteration of
renin release. Pharmacol Rev 31:81—227, 1981
41. VANDER J, GEELHOED GW: Inhibition of renin secretion by angio-
tensin II. Proc Soc Exp Biol Med 120:399—403, 1%5
42. HACKENTHAL E, PAUL M, GANTEN D, TAUGNER R: Morphology,
physiology, and molecular biology of renin secretion. Physio! Rev
70:1067—1115, 1990
43. PUPILLI C, CHEVALIER RL, CAREY RM, GOMEZ RA: Distribution
and content of renin and renin mRNA in remnant kidney of adult
rat. Am J Physiol (Renal, Fluid Electrol Physiol) 263:F73l—F738,
1992
